PIPELINE

With a focus on colorectal, gastroenterology, and urological diseases, Oceana Therapeutics actively pursues worldwide opportunities to acquire, develop and maximize the therapeutic potential of approved/in-market and late-stage products – principally devices, pharmaceuticals, and diagnostics – offering broader control and greater efficiencies for achieving optimal outcomes and patient well-being. Founded in mid-2008, Oceana acquired its first commercial assets in mid-2009 and has since initiated worldwide operations. The Company is now also actively pursuing opportunities to acquire late-stage development products.

Please contact products@oceanathera.com or bisdev@oceanathera.com if there is a product or product prospect in late-stage development that meets our selective acquisition criteria.